Back | Next |
home / stock / ikt / ikt message board
Subject | By | Source | When |
---|---|---|---|
MomentumIts trading up | conix | investorshub | 04/14/2023 8:29:59 PM |
Good read | conix | investorshub | 04/14/2023 2:11:21 PM |
MomentumIts now | estreet7883 | investorshub | 04/14/2023 11:10:42 AM |
The trading | ProfitScout | investorshub | 04/14/2023 4:54:02 AM |
$IKT short squeeze article | TrendTrade2016 | investorshub | 04/14/2023 2:55:01 AM |
$IKT What do you make of this? | INFINITI | investorshub | 04/14/2023 2:32:56 AM |
$IKT and the shorts continue | conix | investorshub | 04/14/2023 1:28:48 AM |
$IKT What do you make of this? | conix | investorshub | 04/13/2023 9:04:43 PM |
$IKT The gaining | ProfitScout | investorshub | 04/13/2023 7:26:57 PM |
The trading | conix | investorshub | 04/13/2023 4:40:30 PM |
$IKT great news | ProfitScout | investorshub | 04/13/2023 1:29:32 PM |
$IKT news out | jedijazz | investorshub | 04/13/2023 11:54:29 AM |
$IKT Price trading | ProfitScout | investorshub | 04/13/2023 11:49:26 AM |
short data if anyone is interested | conix | investorshub | 04/13/2023 10:18:00 AM |
When is this gonna take off? | conix | investorshub | 04/13/2023 9:49:57 AM |
$IKT are we finally gonna see some action | conix | investorshub | 04/13/2023 5:41:09 AM |
$IKT Price now | conix | investorshub | 04/13/2023 4:34:38 AM |
Price gaining last up | conix | investorshub | 04/13/2023 1:21:30 AM |
$IKT Found an interesting article | conix | investorshub | 04/13/2023 12:41:37 AM |
$IKT MomentumIts trading | jedijazz | investorshub | 04/12/2023 10:46:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
Inhibikase Therapeutics Inc. Website:
BOSTON and ATLANTA, June 17, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinso...
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kin...
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...